Table of Contents Author Guidelines Submit a Manuscript
International Journal of Nephrology
Volume 2018, Article ID 4310379, 7 pages
https://doi.org/10.1155/2018/4310379
Review Article

Vascular Calcification in Chronic Kidney Disease: The Role of Inflammation

1Department of Nephropathology, Friedrich-Alexander University (FAU) Erlangen-Nürnberg, Germany
2Department of Nephrology and Hypertension, Friedrich-Alexander University (FAU) Erlangen-Nürnberg, Germany

Correspondence should be addressed to Kerstin Amann; ed.negnalre-ku@nnama.nitsrek

Received 18 April 2018; Accepted 24 July 2018; Published 13 August 2018

Academic Editor: Nicolas Verheyen

Copyright © 2018 Kerstin Benz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Amann, C. Wanner, and E. Ritz, “Cross-talk between the kidney and the cardiovascular system,” Journal of the American Society of Nephrology, vol. 17, no. 8, pp. 2112–2119, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Wanner, K. Amann, and T. Shoji, “The heart and vascular system in dialysis,” The Lancet, vol. 388, no. 10041, pp. 276–284, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Amann and E. Ritz, “Microvascular disease—the Cinderella of uraemic heart disease,” Nephrology Dialysis Transplantation, vol. 15, no. 10, pp. 1493–1503, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Amann, “Cardiovascular changes in chronic renal failure—pathogenesis and therapy,” Clinical Nephrology, vol. 58, 1, pp. S62–S72, 2002. View at Google Scholar
  5. K. Amann and E. Ritz, “The heart in renal failure: morphological changes of the myocardiom - new insights,” Journal of Clinical and Basic Cardiology, vol. 4, pp. 109–113, 2001. View at Google Scholar
  6. R. Dikow, L. P. Kihm, M. Zeier et al., “Increased infarct size in uremic rats: Reduced ischemia tolerance?” Journal of the American Society of Nephrology, vol. 15, no. 6, pp. 1530–1536, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Himmelfarb, P. Stenvinkel, T. A. Ikizler, and R. M. Hakim, “The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia,” Kidney International, vol. 62, no. 5, pp. 1524–1538, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Faul, A. P. Amaral, B. Oskouei et al., “FGF23 induces left ventricular hypertrophy,” The Journal of Clinical Investigation, vol. 121, no. 11, pp. 4393–4408, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Amann, P. Gassmann, M. Buzello et al., “Effects of ACE inhibition and bradykinin antagonism on cardiovascular changes in uremic rats,” Kidney International, vol. 58, no. 1, pp. 153–161, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Amann, J. Hofstetter, V. Câmpean et al., “Nonhypotensive dose of β-adrenergic blocker ameliorates capillary deficits in the hearts of rats with moderate renal failure,” Virchows Archiv, vol. 449, no. 2, pp. 207–214, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Amann, K. Münter, S. Wessels et al., “Endothelin a receptor blockade prevents capillary/myocyte mismatch in the heart of uremic animals,” Journal of the American Society of Nephrology, vol. 11, no. 9, pp. 1702–1711, 2000. View at Google Scholar · View at Scopus
  12. K. Amann, K. Tyralla, M.-L. Gross et al., “Cardiomyocyte loss in experimental renal failure: Prevention by ramipril,” Kidney International, vol. 63, no. 5, pp. 1708–1713, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. G. S. Di Marco, S. Reuter, D. Kentrup et al., “Treatment of established left ventricular hypertrophy with fibroblast growth factor receptor blockade in an animal model of CKD,” Nephrology Dialysis Transplantation , vol. 29, no. 11, pp. 2028–2035, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. V. Campean, D. Neureiter, I. Varga et al., “Atherosclerosis and vascular calcification in chronic renal failure,” Kidney and Blood Pressure Research, vol. 28, no. 5-6, pp. 280–289, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Amann, “Media calcification and intima calcification are distinct entities in chronic kidney disease,” Clinical Journal of the American Society of Nephrology, vol. 3, no. 6, pp. 1599–1605, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. W. G. Goodman, “Vascular calcification in end-stage renal disease,” Journal of Nephrology, vol. 15, no. 6, pp. S82–S85, 2002. View at Google Scholar
  17. W. G. Goodman, J. Goldin, B. D. Kuizon et al., “Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis,” The New England Journal of Medicine, vol. 342, no. 20, pp. 1478–1483, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. M.-L. Gross, H.-P. Meyer, H. Ziebart et al., “Calcification of coronary intima and media: Immunohistochemistry, backscatter imaging, and x-ray analysis in renal and nonrenal patients,” Clinical Journal of the American Society of Nephrology, vol. 2, no. 1, pp. 121–134, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Lindner, B. Charra, D. J. Sherrard, and B. H. Scribner, “Accelerated atherosclerosis in prolonged maintenance hemodialysis,” The New England Journal of Medicine, vol. 290, no. 13, pp. 697–701, 1974. View at Publisher · View at Google Scholar · View at Scopus
  20. G. M. London, A. P. Guérin, S. J. Marchais, F. Métivier, B. Pannier, and H. Adda, “Arterial media calcification in end-stage renal disease: Impact on all-cause and cardiovascular mortality,” Nephrology Dialysis Transplantation , vol. 18, no. 9, pp. 1731–1740, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. G. M. London, S. J. Marchais, and A. P. Guerin, “Arterial stiffness and function in end-stage renal disease,” Advances in Chronic Kidney Disease, vol. 11, no. 2, pp. 202–209, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Amann and E. Ritz, “Cardiovascular abnormalities in ageing and in uraemia - Only analogy or shared pathomechanisms?” Nephrology Dialysis Transplantation , vol. 13, no. 7, pp. 6–11, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. U. Schwarz, M. Buzello, E. Ritz et al., “Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure,” Nephrology Dialysis Transplantation , vol. 15, no. 2, pp. 218–223, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. S. B. Schwedler, K. Amann, K. Wernicke et al., “Native C-reactive protein increases whereas modified C-reactive protein reduces atherosclerosis in apolipoprotein E-knockout mice,” Circulation, vol. 112, no. 7, pp. 1016–1023, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. W. G. Goodman, “Importance of hyperphosphataemia in the cardio-renal axis,” Nephrology Dialysis Transplantation , vol. 19, no. 1, pp. i4–i8, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Amann, M.-L. Gross, G. M. London, and E. Ritz, “Hyperphosphataemia - A silent killer of patients with renal failure?” Nephrology Dialysis Transplantation , vol. 14, no. 9, pp. 2085–2087, 1999. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Ketteler, C. Wanner, T. Metzger et al., “Deficiencies of calcium-regulatory proteins in dialysis patients: A novel concept of cardiovascular calcification in uremia,” Kidney International Supplements, vol. 63, no. 84, pp. S84–S87, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Schäfer, A. Heiss, A. Schwarz et al., “The serum protein -Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification,” The Journal of Clinical Investigation, vol. 112, no. 3, pp. 357–366, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. E. Ishimura, S. Okuno, K. Kitatani et al., “C-reactive protein is a significant predictor of vascular calcification of both aorta and hand arteries,” Seminars in Nephrology, vol. 24, no. 5, pp. 408–412, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Zimmermann, S. Herrlinger, A. Pruy, T. Metzger, and C. Wanner, “Inflammation enhances cardiovascular risk and mortality in hemodialysis patients,” Kidney International, vol. 55, no. 2, pp. 648–658, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. G. A. Block, “Prevalence and clinical consequences of elevated Ca x P product in hemodialysis patients,” Clinical Nephrology, vol. 54, no. 4, pp. 318–324, 2000. View at Google Scholar
  32. G. A. Block, T. E. Hulbert-Shearon, N. W. Levin, and F. K. Port, “Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study,” American Journal of Kidney Diseases, vol. 31, no. 4, pp. 607–617, 1998. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Amann, E. Ritz, G. Wiest, G. Klaus, and G. Mall, “A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia,” Journal of the American Society of Nephrology, vol. 4, no. 10, pp. 1814–1819, 1994. View at Google Scholar · View at Scopus
  34. K. Amann, J. Törnig, B. Kugel et al., “Hyperphosphatemia aggravates cardiac fibrosis and microvascular disease in experimental uremia,” Kidney International, vol. 63, no. 4, pp. 1296–1301, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. S. M. Moe, “Current issues in the management of secondary hyperparathyroidism and bone disease,” Peritoneal Dialysis International, vol. 21, no. 3, pp. S241–S246, 2001. View at Google Scholar
  36. C. M. Giachelli, “Vascular calcification: in vitro evidence for the role of inorganic phosphate,” Journal of the American Society of Nephrology, vol. 14, 4, no. 9, pp. S300–S304, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. N. X. Chen, K. D. O'Neill, D. Duan, and S. M. Moe, “Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells,” Kidney International, vol. 62, no. 5, pp. 1724–1731, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. S. M. Moe, D. Duan, B. P. Doehle, K. D. O'Neill, and N. X. Chen, “Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels,” Kidney International, vol. 63, no. 3, pp. 1003–1011, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. S. M. Moe, K. D. O'Neill, D. Duan et al., “Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins,” Kidney International, vol. 61, no. 2, pp. 638–647, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. C. S. Viegas, L. Santos, A. L. Macedo et al., “Chronic Kidney Disease Circulating Calciprotein Particles and Extracellular Vesicles Promote Vascular Calcification: A Role for GRP (Gla-Rich Protein),” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 38, no. 3, pp. 575–587, 2018. View at Publisher · View at Google Scholar
  41. A. Mehta, J. Patel, M. Al Rifai et al., “Inflammation and coronary artery calcification in South Asians: The Mediators of Atherosclerosis in South Asians Living in America (MASALA) study,” Atherosclerosis, vol. 270, pp. 49–56, 2018. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. S. Hamirani, S. Pandey, J. J. Rivera et al., “Markers of inflammation and coronary artery calcification: A systematic review,” Atherosclerosis, vol. 201, no. 1, pp. 1–7, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. R. Pecoits-Filho, B. Lindholm, and P. Stenvinkel, “The malnutrition, inflammation, and atherosclerosis (MIA) syndrome—the heart of the matter,” Nephrology Dialysis Transplantation, vol. 17, 11, pp. 28–31, 2002. View at Google Scholar · View at Scopus
  44. J. P. Kooman, M. J. Dekker, L. A. Usvyat et al., “Inflammation and premature aging in advanced chronic kidney disease,” American Journal of Physiology-Renal Physiology, vol. 313, no. 4, pp. F938–F950, 2017. View at Publisher · View at Google Scholar · View at Scopus
  45. L. Dai, E. Golembiewska, B. Lindholm, and P. Stenvinkel, “End-Stage Renal Disease, Inflammation and Cardiovascular Outcomes,” Contributions to Nephrology, vol. 191, pp. 32–43, 2017. View at Publisher · View at Google Scholar · View at Scopus
  46. V. Campean, D. Neureiter, B. Nonnast-Daniel, C. Garlichs, M.-L. Gross, and K. Amann, “CD40-CD154 expression in calcified and non-calcified coronary lesions of patients with chronic renal failure,” Atherosclerosis, vol. 190, no. 1, pp. 156–166, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. K. Benz, I. Varga, D. Neureiter et al., “Vascular inflammation and media calcification are already present in early stages of chronic kidney disease,” Cardiovascular Pathology, vol. 27, pp. 57–67, 2017. View at Publisher · View at Google Scholar · View at Scopus
  48. D. L. Wachter, D. Neureiter, V. Campean, K. Hilgers et al., “In-situ analysis of mast cells and dendritic cells in coronary atherosclerosis in chronic kidney disease (CKD),” Histology and Histopathology, 2018. View at Google Scholar
  49. J. Swedenborg, M. I. Mäyränpää, and P. T. Kovanen, “Mast cells: Important players in the orchestrated pathogenesis of abdominal aortic aneurysms,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 4, pp. 734–740, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. Y. V. Bobryshev, R. S. A. Lord, S. Rainer, O. S. Jamal, and V. F. Munro, “Vascular dendritic cells and atherosclerosis,” Pathology - Research and Practice, vol. 192, no. 5, pp. 462–467, 1996. View at Google Scholar · View at Scopus
  51. Y. V. Bobryshev and R. S. A. Lord, “Langhans cells of human arterial intima: Uniform by stellate appearance but different by nature,” Tissue & Cell, vol. 28, no. 2, pp. 177–194, 1996. View at Publisher · View at Google Scholar · View at Scopus
  52. Y. V. Bobryshev and R. S. A. Lord, “Detection of vascular dendritic cells accumulating calcified deposits in their cytoplasm,” Tissue & Cell, vol. 30, no. 3, pp. 383–388, 1998. View at Publisher · View at Google Scholar · View at Scopus
  53. Y. V. Bobryshev and R. S. A. Lord, “Mapping of vascular dendritic cells in atherosclerotic arteries suggests their involvement in local immune-inflammatory reaction,” Cardiovascular Research, vol. 37, no. 3, pp. 799–810, 1998. View at Publisher · View at Google Scholar · View at Scopus
  54. Y. V. Bobryshev, “Dendritic cells and their role in atherogenesis,” Laboratory Investigation, vol. 90, no. 7, pp. 970–984, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. K. E. Paulson, S.-N. Zhu, M. Chen, S. Nurmohamed, J. Jongstra-Bilen, and M. I. Cybulsky, “Resident intimal dendritic cells accumulate lipid and contribute to the initiation of atherosclerosis,” Circulation Research, vol. 106, no. 2, pp. 383–390, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. I. Bot and E. A. L. Biessen, “Mast cells in atherosclerosis,” Thrombosis and Haemostasis, vol. 106, no. 5, pp. 820–826, 2011. View at Publisher · View at Google Scholar · View at Scopus
  57. T. Eleftheriadis, G. Antoniadi, V. Liakopoulos, C. Kartsios, and I. Stefanidis, “Disturbances of acquired immunity in hemodialysis patients,” Seminars in Dialysis, vol. 20, no. 5, pp. 440–451, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. M. Girndt, M. Sester, U. Sester, H. Kaul, and H. Köhler, “Molecular aspects of T- and B-cell function in uremia,” Kidney International Supplements, vol. 59, no. 78, pp. S206–S211, 2001. View at Publisher · View at Google Scholar · View at Scopus
  59. W. H. Lim, S. Kireta, E. Leedham, G. R. Russ, and P. T. Coates, “Uremia impairs monocyte and monocyte-derived dendritic cell function in hemodialysis patients,” Kidney International, vol. 72, no. 9, pp. 1138–1148, 2007. View at Publisher · View at Google Scholar · View at Scopus
  60. M. Hueso, J. Torras, M. Carrera, A. Vidal, E. Navarro, and J. Grinyó, “Chronic Kidney Disease is associated with an increase of Intimal Dendritic cells in a comparative autopsy study,” Journal of Inflammation, vol. 12, p. 26, 2015. View at Publisher · View at Google Scholar
  61. E. A. Van Vré, H. Bult, V. Y. Hoymans, V. F. I. Van Tendeloo, C. J. Vrints, and J. M. Bosmans, “Human C-reactive protein activates monocyte-derived dendritic cells and induces dendritic cell-mediated T-cell activation,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 3, pp. 511–518, 2008. View at Publisher · View at Google Scholar · View at Scopus
  62. I. Bot, M. Bot, S. H. Van Heiningen et al., “Mast cell chymase inhibition reduces atherosclerotic plaque progression and improves plaque stability in ApoE-/- mice,” Cardiovascular Research, vol. 89, no. 1, pp. 244–252, 2011. View at Publisher · View at Google Scholar · View at Scopus
  63. Y. V. Bobryshev, “Targeting vascular calcification: Up-date,” Current Pharmaceutical Design, vol. 20, no. 37, pp. 5799-5800, 2014. View at Publisher · View at Google Scholar · View at Scopus
  64. B. F. Sena, J. L. Figueiredo, and E. Aikawa, “Cathepsin S As an Inhibitor of Cardiovascular Inflammation and Calcification in Chronic Kidney Disease,” Frontiers in Cardiovascular Medicine, vol. 4, p. 88, 2018. View at Publisher · View at Google Scholar